<p>*GMT: geometric mean reciprocal titre.</p>++<p>CL: Exact confidence limits (Mehta, Patel and Gray 1985).</p><p>**Fisher exact.</p
<p><sup>a</sup>Geometric mean reciprocal titers</p><p><sup>b</sup>Geometric mean-fold rise from base...
<p>The blue squares reflect the number of participants in the per-protocol population with a valid a...
<p>(A) HI antibody titer; (B) NT antibody titer. Colored stacked bars give the proportion with titer...
<p><sup>a</sup>Lower Limit of Quantitation determined during method validation of ELISA was 10IU (In...
a<p>Number of subjects with ≥4-fold rise in titres from baseline to day 7 and day 21.</p>b<p>Binomia...
<p>Geomean anti-CS antibody titers are plotted per timepoint at baseline, 1 month after the first va...
<p>Before: before the 2010 HFMD epidemic; after: after the 2010 HFMD epidemic. The lines indicate 95...
<p>Blood samples were collected at day 21 and 33 post prime and on day 28 post challenge during acti...
Data are geometric mean titres (95% CI) at day 28 post second dose. GMRs (95% CI) were adjusted with...
<p><sup>a</sup>Geometric mean reciprocal titers.</p><p><sup>b</sup>Geometric mean-fold rise from bas...
<p>P: Pregnant.</p><p>NP: Non-pregnant.</p><p>GMT: Geometric mean titer.</p><p>GMR: Geometric mean r...
<p>Bars represent the GMT of all animals in each group with error bars representing the 95% confiden...
<p>ARR = first dose with Ad35.CS, and the second and third doses with RTS,S/AS01<sub>B</sub></p><p>R...
<p><sup>a</sup>Geometric mean reciprocal titers.</p><p><sup>b</sup>Geometric mean-fold rise from bas...
A. Comparison of mean N1 Ct values in all specimens, stratified by vaccine type shows negligible eff...
<p><sup>a</sup>Geometric mean reciprocal titers</p><p><sup>b</sup>Geometric mean-fold rise from base...
<p>The blue squares reflect the number of participants in the per-protocol population with a valid a...
<p>(A) HI antibody titer; (B) NT antibody titer. Colored stacked bars give the proportion with titer...
<p><sup>a</sup>Lower Limit of Quantitation determined during method validation of ELISA was 10IU (In...
a<p>Number of subjects with ≥4-fold rise in titres from baseline to day 7 and day 21.</p>b<p>Binomia...
<p>Geomean anti-CS antibody titers are plotted per timepoint at baseline, 1 month after the first va...
<p>Before: before the 2010 HFMD epidemic; after: after the 2010 HFMD epidemic. The lines indicate 95...
<p>Blood samples were collected at day 21 and 33 post prime and on day 28 post challenge during acti...
Data are geometric mean titres (95% CI) at day 28 post second dose. GMRs (95% CI) were adjusted with...
<p><sup>a</sup>Geometric mean reciprocal titers.</p><p><sup>b</sup>Geometric mean-fold rise from bas...
<p>P: Pregnant.</p><p>NP: Non-pregnant.</p><p>GMT: Geometric mean titer.</p><p>GMR: Geometric mean r...
<p>Bars represent the GMT of all animals in each group with error bars representing the 95% confiden...
<p>ARR = first dose with Ad35.CS, and the second and third doses with RTS,S/AS01<sub>B</sub></p><p>R...
<p><sup>a</sup>Geometric mean reciprocal titers.</p><p><sup>b</sup>Geometric mean-fold rise from bas...
A. Comparison of mean N1 Ct values in all specimens, stratified by vaccine type shows negligible eff...
<p><sup>a</sup>Geometric mean reciprocal titers</p><p><sup>b</sup>Geometric mean-fold rise from base...
<p>The blue squares reflect the number of participants in the per-protocol population with a valid a...
<p>(A) HI antibody titer; (B) NT antibody titer. Colored stacked bars give the proportion with titer...